Alex Gibson

Alex Gibson is an accomplished executive with extensive experience in the healthcare and diagnostics sectors. Currently serving as the Chief Executive Officer and Business Development Officer at Edinburgh Molecular Imaging Ltd since March 2017, and concurrently holding a role in Business Development and Strategic Partnerships at Cytox Limited, Alex has a proven track record in supporting small businesses to execute technology partnership strategies. Prior experience includes significant roles at GE Healthcare, where Alex led research alliances and developed a global network for innovation in medical diagnostics, as well as a position at Amersham plc overseeing radiochemistry research. Academically, Alex obtained a Ph.D. in Chemistry and a Bachelor's Degree in Chemistry from the University of Southampton.